IL17RA and colitis: The role of IL-17RA signaling in inflammation has produced conflicting results, as IL-17RA−/− mice were protected from trinitrobenzenesulfonic induced colitis, whereas mice given a neutralizing antibody against IL-17RA experienced exacerbated inflammation in response to DSS-induced colitis (48, 49).